Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Melanoma
Clinical trial register · Australia

Melanoma Trials in Australia, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3370 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:19 UTC
3370
Studies in scope
all four open statuses
1816
Recruiting now
open to new participants
776
Lead sponsors
across recruiting studies
Top sites
Melbourne 12 Wollstonecraft 11 Westmead 9 Waratah 6 Southport 6
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Bristol-Myers Squibb3 Melanoma Institute Australia3 Merck Sharp & Dohme LLC3 Regeneron Pharmaceuticals3 Genentech, Inc.2 AstraZeneca2 Pierre Fabre Medicament2 Melanoma and Skin Cancer Trials Limited1 Pfizer1 ViroMissile, Inc.1 IO Biotech1 Monash University1 Peter MacCallum Cancer Centre, Australia1 ModernaTX, Inc.1 Daiichi Sankyo1 Novartis Pharmaceuticals1 Replimune, Inc.1 Ascentage Pharma Group Inc.1 ImmVira Pharma Co. Ltd1 Onchilles Pharma Inc1 Obsidian Therapeutics, Inc.1 Iovance Biotherapeutics, Inc.1
Site location
Melbourne12 Wollstonecraft11 Westmead9 Waratah6 Southport6 Bedford Park6 Sydney5 Woolloongabba5 North Sydney4 Nedlands4 Greenslopes3 Murdoch3 Brisbane3 Cairns3 Clayton3 East Melbourne3 Box Hill3 North Adelaide3 Hobart3 Heidelberg3 Camperdown2 Newcastle2 Townsville2 Darlinghurst2 Herston2 Show all 54
All 54 locations
Target enrolment
to

Melanoma trials in Australia

33 of 3370 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Intratumoral N17350 in Advanced Solid Tumors
NCT07339176Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative, Squamous Cell Carcinoma of Skin, Melanoma
Onchilles Pharma Inc
Phase 1/2
275
Newcastle, Westmead, Melbourne
2026-05-25
Recruiting
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
NCT06887348Melanoma, Metastatic Melanoma, Advanced Solid Tumor, Hepatocellular Carcinoma
Replimune, Inc.
Observational
50
Southport
2025-12-12
Recruiting
IDOV-Immune for Advanced Solid Tumors
NCT06910657Colorectal Cancer, Pancreatic Cancer, Melanoma, Ovarian Cancer
DrugIDOV-Immune
ViroMissile, Inc.
Phase 1
78
Westmead, Melbourne
2025-08-25
Recruiting
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
NCT07115043Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin), Renal Cell Carcinoma
DrugRilvegostomig
AstraZeneca
Phase 1/2
120
East Melbourne
2025-07-29
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Lismore, Westmead, Wollstonecraft, Douglas, Hervey Bay, Bedford Park, Woodville, Hobart
2024-09-18
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT06172478Advanced Solid Tumor, Melanoma, Head and Neck Cancer, Gastric Cancer
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 2
740
Camperdown, Chermside, Clayton, Hobart, Hyde Park
2024-02-26
Active, closed
Merck Sharp & Dohme LLC
Phase 2
147
Port Macquarie, Frankston
2023-12-26
Recruiting
IO Biotech
Phase 2
60
Sydney, Melbourne
2023-12-21
Recruiting
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
NCT06060613Tumor Skin, Metastatic Melanoma, Melanoma, Lung Cancer
Obsidian Therapeutics, Inc.
Phase 1/2
254
Wollstonecraft
2023-10-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Westmead, Wollstonecraft, Brisbane, Melbourne, Nedlands
2023-07-19
Recruiting
Metabolic Phenotypes in Melanoma
NCT05570227Melanoma
Peter MacCallum Cancer Centre, Australia
Not applicable
240
Melbourne
2023-06-27
Recruiting
Iovance Biotherapeutics, Inc.
Phase 3
670
Greenslopes, Melbourne, Murdoch, Bedford Park, Westmead
2023-03-30
Active, closed
Bristol-Myers Squibb
Phase 3
579
Coffs Harbour, Orange, Port Macquarie, Wagga Wagga, Waratah, Westmead, Wollstonecraft, Birtinya
2023-03-06
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,564
Blacktown, Lismore, Liverpool, Wollstonecraft, Bedford Park, North Adelaide, Box Hill, Geelong
2023-01-16
Active, closed
Pfizer
Phase 1
148
Melbourne, Parkville
2022-11-30
Active, closed
Monash University
Observational
130
Kingswood, Waratah, Bundaberg, Hervey Bay, Ipswich, Toowoomba, Woodville South, Clayton
2022-11-07
Active, closed
Genentech, Inc.
Phase 1
165
Darlinghurst, Clayton, Nedlands
2022-10-20
Active, closed
AstraZeneca
Phase 2
194
Darlinghurst, East Melbourne, Herston, Woolloongabba
2022-08-11
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Southport, Townsville, North Adelaide, Hobart, Geelong, Melbourne
2022-07-14
Active, closed
Pierre Fabre Medicament
Phase 3
815
Sydney, Wollstonecraft, Woolloongabba, North Adelaide, Box Hill, Heidelberg, Prahran, Nedlands
2022-05-02
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT04913285Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Pierre Fabre Medicament
Phase 1
400
Waratah, Wollstonecraft, Southport, Heidelberg, Perth
2021-08-04
Recruiting
Personalised Immunotherapy Platform
NCT06536257Melanoma, Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Merkel Cell Carcinoma
Melanoma Institute Australia
Observational
1,000
Sydney
2021-06-08
Active, closed
Genentech, Inc.
Phase 1
65
Waratah, Melbourne, Nedlands
2021-05-13
Active, closed
Melanoma and Skin Cancer Trials Limited
Not applicable
670
Camperdown, Newcastle, Sydney, Wollstonecraft, Brisbane, Cairns, Townsville, Bendigo
2021-03-03
Active, closed
Novartis Pharmaceuticals
Phase 2
134
North Sydney, Wooloongabba, Subiaco
2020-10-30
Recruiting
ImmVira Pharma Co. Ltd
Phase 1/2
30
Bedford Park, Frankston, Melbourne
2020-09-17
Active, closed
Bristol-Myers Squibb
Phase 3
790
Waratah, Westmead, Wollstonecraft, Cairns, Greenslopes, Herston, Southport, Box Hill
2019-10-28
Active, closed
ModernaTX, Inc.
Phase 2
267
North Sydney, Westmead, Woolloongabba, Murdoch, Subiaco
2019-07-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
North Sydney, Westmead, Cairns, Southport, Woolloongabba, Adelaide, Kurralta Park, Melbourne
2018-09-12
Active, closed
A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors
NCT03611868Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Melanoma, Uveal Melanoma, P53 Mutation
DrugPembrolizumab
Ascentage Pharma Group Inc.
Phase 1/2
230
Brisbane, South Brisbane, Bedford Park, Heidelberg
2018-08-29
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
North Sydney, Waratah, Greenslopes, Southport, Bedford Park, Murdoch
2018-04-11
Active, closed
Melanoma Institute Australia
Phase 2
60
Sydney, Wollstonecraft, Melbourne
2017-11-08
Active, closed
Melanoma Institute Australia
Phase 2
76
Wollstonecraft, Woolloongabba, Adelaide, East Melbourne
2014-11-04
Rows per page Showing 1–33 of 33
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-australia/condition/melanoma

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,370 studies in total at the last sync on 11 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 33 of those studies listing the condition Melanoma.

How many Melanoma trials are recruiting in Australia?

12 of the 33 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 21 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Melanoma), 33 studies
PhaseStudiesRecruitingShare
Phase 29227.3%
Phase 38124.2%
Phase 15215.2%
Phase 1/25415.2%
Observational329.1%
Not applicable216.1%
Phase 2/3103%

Most active sponsors

Lead sponsors with the most studies (Melanoma)
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb30
Melanoma Institute Australia31
Merck Sharp & Dohme LLC30
Regeneron Pharmaceuticals30
AstraZeneca21
Genentech, Inc.20
Pierre Fabre Medicament21
Ascentage Pharma Group Inc.10
Daiichi Sankyo11
ImmVira Pharma Co. Ltd11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.